Literature DB >> 19261099

Synchronous chromophobe and papillary renal cell carcinoma. First report and review of the pathogenesis theories.

Stavros Ioannis Tyritzis1, Paraskevi Theodoros Alexandrou, Vasileios Migdalis, George Koritsiadis, Ioannis Anastasiou.   

Abstract

The coexistence of different subtypes of renal cell carcinoma (RCC) within a single kidney is an extremely unusual entity. Presented herein is the case of a 57-year-old man with two RCC of chromophobe and papillary histology. Very few reports in the literature describe double or triple synchronous renal neoplasms. To our knowledge this is the first report of this RCC subtype combination, which might trigger further investigation on the RCC pathogenesis theories.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261099     DOI: 10.1111/j.1440-1827.2009.02350.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

1.  Two different renal cell carcinomas and multiple angiomyolipomas in a patient with tuberous sclerosis.

Authors:  Sung Gu Kang; Young Hwii Ko; Seok Ho Kang; Jin Kim; Chul Hwan Kim; Hong Seok Park; Du Geon Moon; Jeong Gu Lee; Je Jong Kim; Jun Cheon
Journal:  Korean J Urol       Date:  2010-10-21

2.  Coexistence of a colon carcinoma with two distinct renal cell carcinomas: a case report.

Authors:  Alexandros E Papalampros; Athanasios S Petrou; Eleftherios I Mantonakis; Konstantinos I Evangelou; Lambros A Giannopoulos; Georgios G Marinos; Athanasios L Giannopoulos
Journal:  J Med Case Rep       Date:  2011-04-04

3.  Papillary renal cell carcinoma and collecting duct carcinoma combination. A case report and review of synchronous renal cell carcinoma subtypes in the same kidney.

Authors:  Deniz Arık; Mustafa Fuat Açıkalın; Cavit Can
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

4.  Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma.

Authors:  Shanwen Chen; Baiye Jin; Liqi Xu; Guanghou Fu; Hongzhou Meng; Ben Liu; Jun Li; Dan Xia
Journal:  BMC Urol       Date:  2014-11-07       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.